NASDAQ:ANIP
ANI Pharmaceuticals Stock News
$65.62
+0.140 (+0.214%)
At Close: Apr 22, 2024
What Stocks to Invest Today? 3 Pharmaceutical Stocks To Watch
12:15pm, Wednesday, 22'nd Jun 2022
Could these pharmaceutical stocks be worth watching today?
ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences
06:50am, Friday, 20'th May 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer
ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates
12:05pm, Tuesday, 10'th May 2022 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of -250% and 1.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript
11:23am, Tuesday, 10'th May 2022
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive O
ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates
09:47am, Tuesday, 10'th May 2022
ANI (ANIP) delivered earnings and revenue surprises of -250% and 1.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
01:15pm, Monday, 09'th May 2022 Zacks Investment Research
Alimera Sciences (ALIM) delivered earnings and revenue surprises of -26.87% and 8.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
12:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -76.58% and 8.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
06:50am, Tuesday, 19'th Apr 2022
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tu
This Pharmaceutical Stock Can Make You Very Rich
03:24pm, Saturday, 26'th Mar 2022
Pharmaceutical stocks are great wealth builders. But you need to discover how to use them and what to avoid.
Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide
06:42pm, Tuesday, 15'th Mar 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809.09. The S&P also rose, gaining, 1.24% to 4,224.97. Also check this: Executives Sell More Than $25M Of 4 Stocks Leading and Lagging Sectors Consumer discretionary shares climbed by 2.7% on Tuesday. Meanwhile, top gainers in the sector included New Oriental Education & Technology Group Inc. (NYSE: EDU ), up 20% and Shift Technologies, Inc. (NASDAQ: SFT ) up 15%. In trading on Tuesday, energy shares fell by 3.3%. Top Headline US producer prices rose 0.8% from a month ago in February, versus a revised 1.2% increase in the previous month and slightly below analysts’ estimates of 0.9%. Equities Trading UP Incannex Healthcare Limited (NASDAQ: IXHL ) shares shot up 136% to $54.00 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA).
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
05:42pm, Tuesday, 15'th Mar 2022 Seeking AlphaANI Pharmaceuticals Down 25% After Earnings Miss
04:59pm, Tuesday, 15'th Mar 2022 Investing.com
https://www.investing.com/news/stock-market-news/ani-pharmaceuticals-down-25-after-earnings-miss-2785166
ANI Pharma reaches a seven-month low on soft guidance for 2022
02:27pm, Tuesday, 15'th Mar 2022 Seeking Alpha
The shares of ANI Pharmaceuticals <> have approached the lowest level since August after the maker of branded and generic medicines posted a lower than expected guidance for 2022
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
01:42pm, Tuesday, 15'th Mar 2022
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript
ANI Pharma''s Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus
01:31pm, Tuesday, 15'th Mar 2022 Benzinga
ANI Pharmaceuticals Inc''s (NASDAQ: ANIP ) Q4 revenues were $60.9 million , +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for generic pharmaceutical products were $41.6 million, +8% primarily due to the Novitium acquisition and Q3 launch of Nebivolol, tempered by sales declines for Tolterodine and Vancomycin and lower … Full story available on Benzinga.com